Evidence map›Paper›PMID 41089116›Full record

ArticleCureus2025

Rare Neuroendocrine Tumor of the Bladder: A Case Report.

Laritza Fernandez-Claro, Manuel Pizarro-Mondesir, Francisco Baralt-Nazario, Omar E Soto-Aviles

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Laritza Fernandez-ClaroUrology, Universidad Central del Caribe School of Medicine, Bayamon, PRI.
Manuel Pizarro-MondesirUrology, University of Puerto Rico, Medical Sciences Campus, San Juan, PRI.
Francisco Baralt-NazarioUrology, University of Puerto Rico, Medical Sciences Campus, San Juan, PRI.
Omar E Soto-AvilesUrology, Bayamon Medical Center, Bayamon, PRI.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Well-differentiated neuroendocrine tumors (WD-NETs) of the bladder are notably rare, representing only a small subset of neuroendocrine malignancies in this organ. We present a case of an asymptomatic 67-year-old Hispanic male in whom a WD-NET was incidentally identified during routine surveillance cystoscopy, six months following anterior urethroplasty with a buccal mucosal graft. The patient underwent two transurethral resections of the bladder tumor (TURBT). This case highlights the diagnostic challenges associated with WD-NETs given their rarity and reinforces the need for clinical awareness, even in patients without typical risk factors or symptoms.

Indexed as

bladder caneuroendocrine tumor of the bladderneuroendocrin tumorurinary bladder cawell-differentiated neuroendocrine tumor of the bladder

Identifiers

PMID41089116
PMCPMC12516618

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.